A computational model to predict severity of atopic eczema from 30 serum proteins - 06/10/16

| The authors were supported by the Helmholtz Association (grant no. VH-NG-923), the Fondation Acteria, the German Research Foundation (grant no. EY97/3-1), the Priority Program of the German Research Foundation (InKoMBio, grant no. Th900/6-2), the European Union (ERC [259294]11), and the Bavarian Academy of Sciences. |
|
| Disclosure of potential conflict of interest: F. J. Theis has received research support from ERC [259294]11. C. B. Schmidt-Weber has received research support from SFB/TR22, Allergopharma, Zeller AG, Pfizer, and the Bavarian Science Foundation; has received consultancy fees from GLS; has provided expert testimony for patent lawyers; has received lecture fees from Leopharma and Allergopharma; has a patent through LetiPharma, PLS Design; and has received travel support from Allergopharma. N. S. Mueller has received research support from the Priority Program of the 20 German Research Foundation (InKoMBio, grant no. Th900/6-2). S. Eyerich has received research support from the Helmholtz Association. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 138 - N° 4
P. 1207 - octobre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
